Based on the Cencora Inc. stock forecast from 11 analysts, the average analyst target price for Cencora Inc. is USD 265.07 over the next 12 months. Cencora Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Cencora Inc. is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Cencora Inc.’s stock price was USD 245.07. Cencora Inc.’s stock price has changed by +2.09% over the past week, +7.63% over the past month and +12.33% over the last year.
No recent analyst target price found for Cencora Inc.
No recent average analyst rating found for Cencora Inc.
Company Overview Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania. Read Less
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services ...Read More
Frequently Asked Questions About Cencora Inc. (COR) Stock
Based on ratings from 11 analysts Cencora Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 9 buy, sell and 6 hold ratings.
COR stock's dividend yield is 0.91%.
Our analysis grades COR stock's dividend yield at F. This means that COR stock's dividend yield is above 50% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this COR may be a average dividend stock for its sector.
Based on targets from 11 analysts, the average taret price for COR is USD 265.07 over the next 12 months. The maximum analyst target price is USD 287 while the minimum anlayst target price is USD 237.
COR stock's Price/Earning ratio is 32.14.
Our analysis grades COR stock's Price / Earning ratio at F. This means that COR stock's Price/Earning ratio is above 50% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this COR may be fairly valued for its sector
The last closing price of COR's stock was USD 245.07.
The most recent market capitalization for COR is USD 46.78B.
Based on targets from 11 analysts, the average taret price for COR is projected at USD 265.07 over the next 12 months.
This means that COR's stock price may go up by +8.16% over the next 12 months.
We can't find any ETFs which contains Cencora Inc.'s stock.
As per our most recent records Cencora Inc. has 46,000 Employees.
Cencora Inc.'s registered address is 1 West First Avenue, Conshohocken, PA, United States, 19428-1800.
You can get more information about it from Cencora Inc.'s website at https://www.cencora.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Cencora Inc. (COR) Stock
Based on ratings from 11 analysts Cencora Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 9 buy, sell and 6 hold ratings.
COR stock's dividend yield is 0.91%.
Our analysis grades COR stock's dividend yield at F. This means that COR stock's dividend yield is above 50% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this COR may be a average dividend stock for its sector.
Based on targets from 11 analysts, the average taret price for COR is USD 265.07 over the next 12 months. The maximum analyst target price is USD 287 while the minimum anlayst target price is USD 237.
COR stock's Price/Earning ratio is 32.14.
Our analysis grades COR stock's Price / Earning ratio at F. This means that COR stock's Price/Earning ratio is above 50% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this COR may be fairly valued for its sector
The last closing price of COR's stock was USD 245.07.
The most recent market capitalization for COR is USD 46.78B.
Based on targets from 11 analysts, the average taret price for COR is projected at USD 265.07 over the next 12 months.
This means that COR's stock price may go up by +8.16% over the next 12 months.
We can't find any ETFs which contains Cencora Inc.'s stock.
As per our most recent records Cencora Inc. has 46,000 Employees.
Cencora Inc.'s registered address is 1 West First Avenue, Conshohocken, PA, United States, 19428-1800.
You can get more information about it from Cencora Inc.'s website at https://www.cencora.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for COR !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
